Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer (99m)Tc-HP-Ark2: a pilot study

BACKGROUND: Due to the temporal and spatial heterogeneity of human epidermal growth factor receptor 2 (HER2) expression in breast tumors, immunohistochemistry (IHC) cannot accurately reflect the HER2 status in real time, which may cause misguided treatment decisions. HER2-specific imaging can noninv...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jiyun, Du, Shuaifan, Wang, Rongxi, Gao, Hannan, Luo, Qi, Hou, Guozhu, Zhou, Yidong, Zhu, Zhaohui, Wang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835228/
https://www.ncbi.nlm.nih.gov/pubmed/36631812
http://dx.doi.org/10.1186/s12967-022-03865-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835228/
https://www.ncbi.nlm.nih.gov/pubmed/36631812
http://dx.doi.org/10.1186/s12967-022-03865-y

Ejemplares similares